|
|
 |
|
Viewing report
|
|
 |
BiPar Sciences, Inc.
Sheila Greco Associates, May 2011, Pages: 1
BiPar Sciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing a novel class of tumor-selective drugs designed to meet the significant unmet needs of cancer patients.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
 |
|
|